Sudhakar Katakam

Array ( [id] => 20459393 [patent_doc_number] => 20260008816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-08 [patent_title] => CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF [patent_app_type] => utility [patent_app_number] => 19/329358 [patent_app_country] => US [patent_app_date] => 2025-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19329358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20736770 [patent_doc_number] => 20260146063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-28 [patent_title] => CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF [patent_app_type] => utility [patent_app_number] => 19/329353 [patent_app_country] => US [patent_app_date] => 2025-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19329353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20335461 [patent_doc_number] => 20250339581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-06 [patent_title] => SYNTHETIC HYDROGEL CARRIERS FOR MUSCLE REPAIR [patent_app_type] => utility [patent_app_number] => 19/276532 [patent_app_country] => US [patent_app_date] => 2025-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19276532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20048335 [patent_doc_number] => 20250186557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-12 [patent_title] => MANUFACTURE, FORMULATION AND DOSING OF APRAGLUTIDE [patent_app_type] => utility [patent_app_number] => 19/039081 [patent_app_country] => US [patent_app_date] => 2025-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37322 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19039081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20771528 [patent_doc_number] => 12655188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-16 [patent_title] => Compounds containing one or more diboronates and related insulin analogs [patent_app_type] => utility [patent_app_number] => 18/632799 [patent_app_country] => US [patent_app_date] => 2024-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 90682 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18632799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19477458 [patent_doc_number] => 20240325500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => MANUFACTURE, FORMULATION AND DOSING OF APRAGLUTIDE [patent_app_type] => utility [patent_app_number] => 18/619647 [patent_app_country] => US [patent_app_date] => 2024-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41519 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18619647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19389409 [patent_doc_number] => 20240279279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => PROTEIN-DERIVED PEPTIDE FOR IMPROVING IMMUNITY AGAINST 2019 NOVEL CORONAVIRUS (2019-nCoV) AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/582848 [patent_app_country] => US [patent_app_date] => 2024-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18582848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462475 [patent_doc_number] => 20240316144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITING ANGIOGENESIS [patent_app_type] => utility [patent_app_number] => 18/434663 [patent_app_country] => US [patent_app_date] => 2024-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2948 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18434663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19601076 [patent_doc_number] => 20240391956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => STAPLED PEPTIDES AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 18/427677 [patent_app_country] => US [patent_app_date] => 2024-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49672 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18427677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19737209 [patent_doc_number] => 12214017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-04 [patent_title] => GLP-1 compositions and uses thereof [patent_app_type] => utility [patent_app_number] => 18/427270 [patent_app_country] => US [patent_app_date] => 2024-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5329 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18427270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19157717 [patent_doc_number] => 20240150424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => DIRECTED CHEMICAL CONJUGATE OF GLUCAGON-LIKE PEPTIDE-2 MUTANT, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/417994 [patent_app_country] => US [patent_app_date] => 2024-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19389411 [patent_doc_number] => 20240279281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => Peptide Inhibitors of Interleukin-23 Receptor [patent_app_type] => utility [patent_app_number] => 18/412678 [patent_app_country] => US [patent_app_date] => 2024-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37622 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18412678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19389408 [patent_doc_number] => 20240279278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => NMU RECEPTOR 2 AGONISTS [patent_app_type] => utility [patent_app_number] => 18/409886 [patent_app_country] => US [patent_app_date] => 2024-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20610 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18409886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19692820 [patent_doc_number] => 20250011365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/399726 [patent_app_country] => US [patent_app_date] => 2023-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18318 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18399726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19139645 [patent_doc_number] => 20240138406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => ANTIMICROBIAL PEPTIDE SCYAMPCIN44-63 AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/398278 [patent_app_country] => US [patent_app_date] => 2023-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18398278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20059219 [patent_doc_number] => 20250197441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => Safety-Catch Linkers for Solid Phase Peptide Synthesis [patent_app_type] => utility [patent_app_number] => 18/545556 [patent_app_country] => US [patent_app_date] => 2023-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5264 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18545556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19477459 [patent_doc_number] => 20240325501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => COMPOSITIONS AND METHODS TO SUPPRESS TUMOR GROWTH IN BONE, PREVENT CACHECTIC MUSCLE LOSS, AND PRESERVE SKELETAL INTEGRITY [patent_app_type] => utility [patent_app_number] => 18/538576 [patent_app_country] => US [patent_app_date] => 2023-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23165 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18538576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19217820 [patent_doc_number] => 20240182524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => CYCLIC PEPTIDOMIMETIC FOR THE TREATMENT OF NEUROLOGICAL DISORDERS [patent_app_type] => utility [patent_app_number] => 18/531607 [patent_app_country] => US [patent_app_date] => 2023-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18531607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19246946 [patent_doc_number] => 20240197930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => PET TRACER [patent_app_type] => utility [patent_app_number] => 18/529406 [patent_app_country] => US [patent_app_date] => 2023-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8046 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18529406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19265691 [patent_doc_number] => 20240209390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 18/523380 [patent_app_country] => US [patent_app_date] => 2023-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22353 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18523380 [rel_patent_id] =>[rel_patent_doc_number] =>)